| 2008-11 |
Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of 188Re-DXR-liposome in C26 colon carcinoma ascites mice model |
Nuclear Medicine and Biology. 2008 Nov;35(8):883-893. |
 |
| 2013-08-01 |
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression |
Cell. 2013 Aug 1;154(3):556-568. |
|
| 2015-07 |
Pharmacological induction of human fetal globin gene in hydroxyurea-resistant primary adult erythroid cells |
Molecular and Cellular Biology. 2015 Jul;35(14):2541-2553. |
|
| 2020-06 |
Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice |
European Journal of Vascular and Endovascular Surgery. 2020 Jun;59(6):990-999. |
|
| 2013-10-11 |
Pharmacological profiles of oligomerized mu-opioid receptors |
Cells. 2013 Oct 11;2(4):689-714. |
|
| 2020-04 |
Pharmacological studies of morphine in a novel humanized mu opioid receptor mouse model |
FASEB Journal. 2020 Apr;34(S1):Abstract number 02835. |
|
| 2022-11-17 |
Pharmacometabolomic study of drug response to antihypertensive medications for hypertension marker identification in Han Chinese individuals in Taiwan |
Computational and Structural Biotechnology Journal. 2022 Nov 17;20:6458-6466. |
|
| 2017-12-28 |
Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection |
BMC Bioinformatics. 2017 Dec 28;18(Suppl. 16):Article number 548. |
|
| 2023-06 |
Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors |
Journal of Clinical Oncology. 2023 Jun;41(16, Suppl.):Meeting Abstract 3148. |
|
| 2022-02 |
Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors |
Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660. |
|
| 2021-06-12 |
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers |
Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253. |
|
| 2021-05 |
A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy |
Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025. |
|
| 2022-02-01 |
A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1 |
Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):378. |
|
| 2017-09 |
A Phase 3 Study of nivolumab (Nivo) in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Updated results and subset analysis by PD-L1 expression (ATTRACTION-02) |
Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 617O. |
|
| 2002 |
Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma |
International Journal of Cancer. 2002;Suppl. 13:336-337. |
|
| 2006-11 |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma |
Cancer Chemotherapy and Pharmacology. 2006 Nov;58(5):654-664. |
|
| 2021-03-01 |
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors |
Scientific Reports. 2021 Mar 1;11:Article number 4834. |
|
| 2021-04 |
Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors |
Oncologist. 2021 Apr;26(4):e567-e579. |
|
| 2016-02 |
Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors |
Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745. |
|
| 1997-07 |
A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions |
Anti-Cancer Drugs. 1997 Jul;8(6):565-573. |
|
| 2013-12 |
Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma |
Journal of Hepatology. 2013 Dec;59(6):1271-1277. |
|
| 2021-05 |
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia |
Cancer Medicine. 2021 May;10(9):2946-2955. |
|
| 2020-05 |
Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1, in patients with pretreated biliary tract cancer |
Journal for ImmunoTherapy of Cancer. 2020 May;8(1):Article number e00056. |
|
| 2021-07 |
A phase I study of biweekly abraxane in combination with oxaliplatin and oral S-1/leucovorin as first line treatment for advanced gastric, pancreatic and biliary tract cancers |
Annals of Oncology. 2021 Jul;32(Suppl. 3):S146-S147. |
|
| 2006-05 |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer |
Journal of Gastroenterology and Hepatology. 2006 May;21(5):874-879. |
|
